Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

IPO/Stock Watch

Market trends, bell-weather stocks, filings and IPOs...

Adagene of Suzhou Files for $125 Million US IPO

Gracell Raises $209 Million in US IPO for Novel CAR-T Therapies

APT Medical Closes $191 Million Shanghai STAR Board IPO

Jacobio, a Beijing Biopharma, Raises $174 Million in Hong Kong IPO

Harbour BioMed Raises $221 Million in Hong Kong IPO

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China